ARVN Stock Analysis: Buy, Sell, or Hold?
ARVN - Arvinas, Inc
$8.06
0.03 (0.37%)
▲
5d:
-1.95%
30d:
-3.93%
90d:
-23.31%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When ARVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ARVN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ARVN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: ARVN is currently trading at $8.06, which is considered fair relative to its 30-day fair value range of $8.01 to $8.40.
Technical Outlook: Technically, ARVN is in a strong downtrend. The price is currently testing key support at $7.89. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ARVN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.79 (+83.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARVN is in a strong downtrend. The price is currently testing key support at $7.89. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ARVN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.79 (+83.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$8.01 -
$8.40
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 83.4% below Wall St target ($14.79)
Trading Range Analysis
30-Day Trading Range
$8.01 -
$8.40
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$7.90
Resistance Level
$8.40
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.42
Wall Street Target
$14.79
(+83.4%)
Revenue Growth (YoY)
-91.7%
Profit Margin
-247.5%
Share & Embed Analysis
Last updated: August 03, 2026 8:00 PM ET
Data refreshes hourly during market hours. Next update: 9:00 PM
Data refreshes hourly during market hours. Next update: 9:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARVN showing a specific setup today?
Insider Activity (6 Months)
1
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Noah Berkowitz
SELL
6435 shares
2026-03-18
Briggs Morrison
BUY
20000 shares
2026-03-06
John G Houston
SELL
35297 shares
2026-02-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$52 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 58 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$267 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 56 HOLD |
Advanced ARVN Option Strategies
Professional options setups generated by AI based on today's ARVN price and gamma walls.
